Setting of Methods for Analysis of Mucosal Antibodies in Seminal and Vaginal Fluids of HIV Seropositive Subjects from Cambodian and Italian Cohorts

BACKGROUND Genital mucosae play a key role in protection from STD and HIV infection, due to their involvement in both horizontal and vertical disease transmission. High variability of published observations concerning IgA isolation and quantification underlies the strong requirement of specific methods able to maximize investigation on HIV-specific IgA. METHODOLOGY Genital fluids from 109 subjects, including male and female cohorts from Italy and Cambodia, were collected, aliquoted and processed with different techniques, to assess optimal conditions maximizing mucosal antibody recovery. Three sampling techniques, up to sixteen preservation conditions, six ELISA methods and four purifications protocols were compared. PRINCIPAL FINDINGS The optimal method here described took advantage of Weck-Cel sampling of female mucosal fluids. Immediate processing of genital fluids, with the addition of antibiotics and EDTA, improved recovery of vaginal IgA, while the triple addition of EDTA, antibiotics and protease inhibitors provided the highest amount of seminal IgA. Due to low amount of IgA in mucosal fluids, a high sensitive sandwich ELISA assay was set; sensitivity was enhanced by milk-based overcoating buffer and by a two-step biotin-streptavidin signal amplification. Indeed, commercial antisera to detect human immunoglobulins showed weak cross-reactivity to different antibody types. Three-step affinity purification provided reproducible immunoglobulin recovery from genital specimens, while conventional immuno-affinity IgA purification was found poorly manageable. Affinity columns were suitable to isolate mucosal IgA, which are ten-fold less concentrated than IgG in genital specimens, and provided effective separation of IgA monomers, dimers, and J-chains. Jacalin-bound resin successfully separated IgA1 from IgA2 subfraction. CONCLUSIONS/SIGNIFICANCE Specific, effective and reliable methods to study local immunity are key items in understanding host mucosal response. The sequence of methods here described is effective and reliable in analysing humoral local responses, and may provide a solid advance to identify and measure the effective mucosal responses to HIV.

[1]  R. Detels The 'immunologic advantage' of HIV-exposed seronegative individuals , 2009 .

[2]  J. Fahey,et al.  A new strategy to understand how HIV infects women: identification of a window of vulnerability during the menstrual cycle. , 2008, AIDS.

[3]  J. Mestecky,et al.  Neutralizing antibodies in mucosal secretions: IgG or IgA? , 2007, Current HIV research.

[4]  J. Mestecky Humoral immune responses to the human immunodeficiency virus type-1 (HIV-1) in the genital tract compared to other mucosal sites. , 2006, Journal of reproductive immunology.

[5]  T. Lehner,et al.  Innate and Adaptive Mucosal Immunity in Protection against HIV Infection , 2006, Advances in dental research.

[6]  J. Mestecky,et al.  Human Male Genital Tract Secretions: Both Mucosal and Systemic Immune Compartments Contribute to the Humoral Immunity1 , 2005, The Journal of Immunology.

[7]  T. Quinn,et al.  HIV/AIDS in Women: An Expanding Epidemic , 2005, Science.

[8]  A. Trkola,et al.  Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies , 2005, Nature Medicine.

[9]  M. Mulligan,et al.  Paucity of antigen-specific IgA responses in sera and external secretions of HIV-type 1-infected individuals. , 2004, AIDS research and human retroviruses.

[10]  L. Lopalco,et al.  CCR5-specific mucosal IgA in saliva and genital fluids of HIV-exposed seronegative subjects. , 2004, Blood.

[11]  L. Lopalco Humoral immunity in HIV-1 exposure: cause or effect of HIV resistance? , 2004, Current HIV research.

[12]  P. Reichelderfer,et al.  Recent observations on HIV type-1 infection in the genital tract of men and women. , 2003, AIDS.

[13]  P. Goepfert,et al.  Detection of mucosal antibodies in HIV type 1-infected individuals. , 2002, AIDS research and human retroviruses.

[14]  R. Lynch,et al.  Differential Induction of Mucosal and Systemic Antibody Responses in Women After Nasal, Rectal, or Vaginal Immunization: Influence of the Menstrual Cycle1 , 2002, The Journal of Immunology.

[15]  A. Lackner,et al.  The mucosal immune system: primary target for HIV infection and AIDS. , 2001, Trends in immunology.

[16]  H. Katinger,et al.  Protection of neonatal macaques against experimental SHIV infection by human neutralizing monoclonal antibodies. , 2001, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

[17]  L. Lopalco,et al.  Mucosal and plasma IgA from HIV-exposed seronegative individuals neutralize a primary HIV-1 isolate , 2000, AIDS.

[18]  T. D. Pack,et al.  Purification of Human IgA , 2000, Current protocols in immunology.

[19]  R. Lynch,et al.  Modified wick method using Weck-Cel sponges for collection of human rectal secretions and analysis of mucosal HIV antibody. , 2000, Journal of acquired immune deficiency syndromes.

[20]  J. Mestecky,et al.  False positivity of enzyme-linked immunosorbent assay for measurement of secretory IgA antibodies directed at HIV type 1 antigens. , 2000, AIDS research and human retroviruses.

[21]  M. Kazatchkine,et al.  An ELISA method to measure total and specific human secretory IgA subclasses based on selective degradation by IgA1-protease. , 2000, Journal of immunological methods.

[22]  J. Mascola,et al.  Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies , 2000, Nature Medicine.

[23]  M. Bomsel,et al.  Infectious human immunodeficiency virus can rapidly penetrate a tight human epithelial barrier by transcytosis in a process impaired by mucosal immunoglobulins. , 1999, The Journal of infectious diseases.

[24]  Peter H. Westfall,et al.  Multiple Testing of General Contrasts Using Logical Constraints and Correlations , 1997 .

[25]  L. Bergmeier,et al.  Induction of mucosal and systemic immunity to a recombinant simian immunodeficiency viral protein. , 1992, Science.

[26]  R. Arnold,et al.  Separation of human IgA1 and IgA2 using jacalin-agarose chromatography. , 1987, Journal of immunological methods.

[27]  B Guss,et al.  Structure of the IgG‐binding regions of streptococcal protein G. , 1986, The EMBO journal.

[28]  S. Sirisinha,et al.  Degradation of immunoglobulins by secretions of human reproductive tracts. , 1974, Journal of reproduction and fertility.

[29]  R. Gnanadesikan,et al.  Probability plotting methods for the analysis of data. , 1968, Biometrika.

[30]  R. Detels The 'immunologic advantage' of HIV-exposed seronegative individuals. , 2009, AIDS.

[31]  K. Tanzawa,et al.  BIOLOGICAL ACTIVITIES , 2006 .

[32]  K. Mostov,et al.  Chapter 12 – Immunoglobulin Transport and the Polymeric Immunoglobulin Receptor , 2005 .